The estimated Net Worth of Armon Sharei is at least $820 Tysiąc dollars as of 12 January 2022. Dr Sharei owns over 13,000 units of SQZ Biotechnologies Co stock worth over $127,196 and over the last 4 years he sold SQZ stock worth over $0. In addition, he makes $692,569 as Co-Founder, Pres, CEO oraz Interim Principal Financial Officer & Director at SQZ Biotechnologies Co.
Sign up
Dr D SQZ stock SEC Form 4 insiders trading
Dr has made over 4 trades of the SQZ Biotechnologies Co stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 13,000 units of SQZ stock worth $23,530 on 12 January 2022.
The largest trade he's ever made was exercising 13,000 units of SQZ Biotechnologies Co stock on 12 January 2022 worth over $23,530. On average, Dr trades about 3,839 units every 41 days since 2020. As of 12 January 2022 he still owns at least 285,448 units of SQZ Biotechnologies Co stock.
You can see the complete history of Dr Sharei stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Armon R. Sharei Ph.D. biography
Dr. Armon R. Sharei Ph.D. is the Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director at SQZ Biotechnologies Co.
What is the salary of Dr D?
As the Co-Founder, Pres, CEO oraz Interim Principal Financial Officer & Director of SQZ Biotechnologies Co, the total compensation of Dr D at SQZ Biotechnologies Co is $692,569. There are no executives at SQZ Biotechnologies Co getting paid more.
How old is Dr D?
Dr D is 34, he's been the Co-Founder, Pres, CEO oraz Interim Principal Financial Officer & Director of SQZ Biotechnologies Co since . There are 8 older and no younger executives at SQZ Biotechnologies Co. The oldest executive at SQZ Biotechnologies Co is Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD, 72, who is the Co-Founder & Member of Scientific Advisory Board.
What's Dr D's mailing address?
Armon's mailing address filed with the SEC is 200 ARSENAL YARDS BLVD, SUITE 210, , WATERTOWN, MA, 02472.
Insiders trading at SQZ Biotechnologies Co
Over the last 4 years, insiders at SQZ Biotechnologies Co have traded over $3,939 worth of SQZ Biotechnologies Co stock and bought 2,233,026 units worth $35,530,795 . The most active insiders traders include Holdings (Private) Ltd Temasek, Public Equities, L.P.Minne ... oraz Amy W Schulman. On average, SQZ Biotechnologies Co executives and independent directors trade stock every 50 days with the average trade being worth of $78,593. The most recent stock trade was executed by Richard Capasso on 15 August 2022, trading 1,183 units of SQZ stock currently worth $3,939.
What does SQZ Biotechnologies Co's logo look like?
Complete history of Dr Sharei stock trades at SQZ Biotechnologies Co
SQZ Biotechnologies Co executives and stock owners
SQZ Biotechnologies Co executives and other stock owners filed with the SEC include:
-
Dr. Armon R. Sharei Ph.D.,
Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director -
Teri Loxam,
Consultant & Advisor -
Dr. Howard Bernstein M.D., Ph.D.,
Chief Scientific Officer -
Lawrence J. Knopf,
Gen. Counsel & Sec. -
Micah Zajic,
Chief Bus. Officer -
Ipsita Roymoulik Ph.D.,
Sr. VP of CMC & QUALITY -
Dr. Marshelle Smith Warren M.D.,
Chief Medical Officer -
David First,
Chief People Officer -
Dr. Howard Bernstein,
Chief Scientific Officer -
Richard V. Capasso CPA,
Chief Accounting Officer -
Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
Co-Founder & Member of Scientific Advisory Board -
Micah Zajic,
Chief Financial Officer -
Howard Phd Md Bernstein,
Interim Chief Executive Office -
Holdings (Private) Ltd Temasek,
10% owner -
Oliver Rosen,
Chief Medical Officer -
Paul Bolno,
Director -
Sapna Srivastava,
Director -
Teri Loxam,
Chief Financial Officer -
Pushkal Garg,
Director -
Klavs F. Jensen,
Director -
International Group, Inc. A...,
10% owner -
Marc Elia,
Director -
David First,
Chief People Officer -
Armon Sharei,
President and CEO -
Amy W Schulman,
Director -
Marc Schegerin,
Director -
Lawrence J Knopf,
General Counsel -
Eric Moessinger,
Director -
Schulman, As Trustee The Ar...,
10% owner -
Public Equities, L.P.Minne ...,
-
Management Co. Vii, L.L.C.P...,
-
Bernard Coulie,
Director -
Patrick V.J.J. Vink,
Director -
Richard Capasso,
See Remarks -
Marshelle Smith Warren,
Chief Medical Officer